Work Area: Trade secrets

Latest content

Surprise change to FDA Purple Book creates risks and opportunities for biosimilar producers

A US patent transparency amendment has mixed implications for the strategies pursued by biologics copycat producers

07 January 2021

All the China IP stories you missed over the holidays

Wuhan injunction drama was far from the only big IP news to come out of China over the festive period

04 January 2021

Three life sciences trade secrets and data strategy lessons

As non-patent assets become increasingly important, pharma and biotech innovators must adapt their IP strategies.

22 December 2020

It’s time for investors to re-assess intangibles

A recent report suggests Wall Street is beginning to realise that the rise of intangible assets has thrown a spanner into time-tested valuation models

12 December 2020

3M’s diversity pioneer on why data and collaboration are key to broadening the innovation pool

After seeing her work recognised by the IPO, the company's assistant chief IP counsel Sandra Nowak spoke with IAM on why some parts of the market are still playing catch-up

04 December 2020

Criminal trade secrets law in China targets foreigners with extra penalties

Likely a response to recent US prosecutions of Chinese nationals, the measures mean foreign companies in China should tread with caution

24 November 2020

Risks and rewards of trade secrets in Europe

Featured in IAM Innovation & Invention Yearbook 2021

Until recently, trade secrets were, apart from a few exceptions, often overlooked in favour of patent rights in terms of the value that they contribute as IP assets.

20 November 2020

“This is becoming an investible space,” says Aon IP head as financial giant rolls out M&A-focused product

Sell-side tool is designed to help the dealmaking community better understand the value of patents and other intangible assets

19 November 2020

Your guide to covid-19 vaccine stakeholders’ IP strategies

IAM examines the approaches taken by – and the issues facing – the leading companies in the race to find effective coronavirus inoculations

19 November 2020

Data is the new frontier in healthcare IP licensing, says award-winning TTO

IAM speaks to the tech transfer office of Oregon Health & Science University about the keys to success in university-industry deal-making

17 November 2020

Get unlimited access to all IAM content